Role of GSK‐3β in Alzheimer's disease pathology
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Glycogen synthase kinase 3β (GSK‐3β) is an important regulatory kinase involved in multiple processes such as metabolic control, embryonic development, cell death, and oncogenesis. It has been found to interact with many molecules associated with Alzheimer's disease (AD) such as the microtubule‐associated protein tau, presenilin 1, the amyloid‐β peptide, the amyloid precursor protein, and acetylcholine. Furthermore, GSK‐3β might be involved in brain aging and longevity. As GSK‐3β is associated with so many components of AD pathology, we review the current data on the role of this kinase in tau hyperphosphorylation, then look at its association with AD‐related molecules and pathways, and finally discuss its involvement in cell death and aging. We attempt to integrate all these data to arrive at the proposition that GSK‐3β is a pivotal molecule in the evolution of AD and that developing drugs directed at this kinase might prove to be beneficial in the treatment of this devastating disease. Drug Dev. Res. 56:491–510, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundke-Iqbal, I., Iqbal, K., Tung, Y. C., Quinlan, M., Wisniewski, H. M., & Binder, L. I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.13.4913 · Cited by 3,676
Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal Forebrain
Whitehouse, P., Price, D., Struble, R., Clark, A., Coyle, J., & DeLong, M. R. (1982) · Science · doi:10.1126/science.7058341 · Cited by 3,627 · cited 2×
“, 1996] and the reduction of acetylcholine is notable in AD brain [Davies and Maloney, 1976; Perry et al., 1977; White et al., 1977; Whitehouse et al., 1982].”
SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · cited 1×
“Indeed, Ab treatment reduced Ach synthesis in cultured neurons [Hoshi et al., 1996] and the reduction of acetylcholine is notable in AD brain [Davies and Maloney, 1976; Perry et al., 1977; White et al., 1977; Whitehouse et al., 1982].”
A protein factor essential for microtubule assembly
Weingarten, M. D., Lockwood, A. H., Hwo, S. Y., & Kirschner, M. W. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.5.1858 · Cited by 3,089
Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“Importantly, GSK-3b has been detected in mitochondria and in the nucleus [Hoshi et al., 1995; Diehl et al., 1998; Ragano-Caracciolo et al., 1998].”
Frequency of Stages of Alzheimer-Related Lesions in Different Age Categories
Braak, H., & Braak, E. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00056-0 · Cited by 1,656
Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils
Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526
Silva, A. J., Kogan, J. H., Frankland, P. W., & Kida, S. (1998) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.21.1.127 · Cited by 1,462 · cited 1×
“CREB also regulates many critical neural processes, such as long-term memory and maintenance of synaptic plasticity [Struthers et al., 1991; Davis et al., 1996; Deisseroth et al., 1996; Silva et al., 1998].”
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366 · cited 1×
“In preclinical and AD patients, reduction of glucose metabolism is well documented [Minoshima et al., 1995; Reiman et al., 1996] and is hypothesized to be the consequence of insulin receptor desensitization [Hoyer, 2000].”
Cited by
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709
Self-citationTargeting acetylcholinesterase and butyrylcholinesterase in dementia
Lane, R. M., Potkin, S. G., & Enz, A. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145705005833 · Cited by 654
Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo
Noble, W., Olm, V., Takata, K., Casey, E., Mary, O., Meyerson, J., Gaynor, K., LaFrancois, J., Wang, L., Kondo, T., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00259-9 · Cited by 509
Leroy, K., Yilmaz, Z., & Brion, J. ‐. (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00795.x · Cited by 404
Planel, E., Richter, K. E. G., Nolan, C. E., Finley, J. E., Liu, L., Wen, Y., Krishnamurthy, P., Herman, M., Wang, L., Schachter, J. B., et al. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4854-06.2007 · Cited by 386
Self-citationHébert, S. S., Papadopoulou, A. S., Smith, P., Galas, M.-C., Planel, E., Silahtaroglu, A. N., Sergeant, N., Buée, L., & De Strooper, B. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq311 · Cited by 322
Self-citationTau protein as a differential biomarker of tauopathies
Sergeant, N., Delacourte, A., & Buée, L. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.020 · Cited by 313
Planel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5561-03.2004 · Cited by 261
Self-citationmiR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo
Smith, P. Y., Hernandez-Rapp, J., Jolivette, F., Lecours, C., Bisht, K., Goupil, C., Dorval, V., Parsi, S., Morin, F., Planel, E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv377 · Cited by 220
Self-citationShahpasand, K., Uemura, I., Saito, T., Asano, T., Hata, K., Shibata, K., Toyoshima, Y., Hasegawa, M., & Hisanaga, S.-I. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5927-11.2012 · Cited by 206
“Tau is a phosphoprotein with multiple phosphorylation sites; mass spectroscopic analysis indicates ten and five major sites in fetal and adult rat brains, respectively (Watanabe et al., 1993; MorishimaKawashima et al., 1995; Planel et al., 2002).”
BackgroundWen, Y., Planel, E., Herman, M., Figueroa, H. Y., Wang, L., Liu, L., Lau, L.-F., Yu, W. H., & Duff, K. E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5245-07.2008 · Cited by 145
“Cyclin dependent kinase 5 (cdk5) and glycogen synthase kinase 3 (GSK3 ) have been identified as prime candidates for pathogenesis (Planel et al., 2002; Drewes, 2004) because they both generate diseaseassociated phospho-epitopes on tau, and they colocalize with filamentous tau aggregates in the…”
BackgroundSelf-citationWu, X., Yang, Z., Zou, J., Gao, H., Shao, Z., Li, C., & Lei, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02179-x · Cited by 88
Sahara, N., Vega, I. E., Ishizawa, T., Lewis, J., McGowan, E., Hutton, M., Dickson, D., & Yen, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02558.x · Cited by 15
“…C and p38 mitogen-activated protein kinase (p38MAPK) are able to phosphorylate tau protein (Yang et al. 1994; Ishiguro et al. 1995; Goedert et al. 1997; Illenberger et al. 1998; Sironi et al. 1998; Reynolds et al. 2000; Taniguchi et al. 2001; Buee-Scherrer and Goedert 2002; Planel et al. 2002).”
Background
Metadata
- Authors
- Planel, E., Sun, X., & Takashima, A.
- Venue
- Drug Development Research
- Publisher
- Wiley
- Published
- 2002-07
- Volume
- 56
- Issue
- 3
- Pages
- 491-510
- ISSN
- 0272-4391 (ISSN-L)
- 1098-2299
- OpenAlex
- W2046892908
- Cited by
- 85
- References
- 44
- FWCI
- 2.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.